NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/24/2026
Back to search
Official data from USPTO
BIOSYNTH CARBOSYNTH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
02/25/2026
Trademark type
Combined
Nice classes
1, 5
Filing date
07/23/2019
Registration date
03/03/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/24/2026
Last transaction
02/25/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
07/01/2019
First use in commerce
07/01/2019
Drawing code
3
Owner type
03
Owner location
Staad, CH
Examiner
MOLINOFF, JEFFREY S.
Current location
Historical data usage
Mark description
The mark consists of the stylized word "BIOSYNTH" in blue on top of a blue rectangle with the stylized word "CARBOSYNTH" in white inside the rectangle with a grey line underneath the rectangle.
Holders and representatives
Holders
Biosynth AG
Representatives
Tara Reedy Sliva DENTONS US LLP
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biochemicals and organic chemicals used as enzyme substratesenzyme inducersaminoglutethimidescarbamazepinesgriseofulvinsprimidonesenzyme inactivatorscultural medium additives for use in the field of microbiology and molecular biology; biochemical and organic chemical reagents for clinical diagnostic laboratory use; biochemical and organic chemicals for use in the manufacture of pharmaceuticals and cosmetics; Chemical reagents for medical research use in the field of immunology; Chemical reagents for medical laboratory analysis purposesfor use as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms
Class 5
Medicinal preparationsphotosensitizing agents used as a dermatologic drug for the treatment of skin cancer by phototherapy; Chemical reagents for medical or veterinarian use; Chemical reagents for use as a culture media for cultures of microorganisms for medical usefor the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposesfor Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosiscoronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposesfor novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities; Organic chemical preparations for medical purposesimmunomodulators with anti-inflammatory properties; Organic chemical preparations and enzymes for medical laboratory analysis purposesfor medical detectionidentification and quantification of strains of pathogenic bacteria; Chemical preparations for medical laboratory analysis purposesfor medical immunological and microbiological blood testing; Chemical preparations for medical laboratory analysis purposesfor medical detection of pathogenic bacteriavarious strains of ListeriaClostridiumBacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposesfor the medical detection and quantification of bacteria strains of Escherichia coli; Medical preparations for the diagnosis of Staphylococus aureusin particular for Methicillin-resistant Staphylococcus aureus (MRSA)
Publications
History of USPTO decisions and trademark events.
26 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/24/2026
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
01/27/2026
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
01/23/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/23/2026
E815
TEAS SECTION 8 & 15 RECEIVED
10/20/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/03/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/18/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/18/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/18/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
03/03/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/17/2019
PUBO
PUBLISHED FOR OPPOSITION
12/17/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/27/2019
ALIE
ASSIGNED TO LIE
11/07/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/04/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/31/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/30/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/30/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/05/2019
GNRT
NON-FINAL ACTION E-MAILED
09/05/2019
CNRT
NON-FINAL ACTION WRITTEN
09/05/2019
DOCK
ASSIGNED TO EXAMINER
09/05/2019
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/01/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/31/2019
NWAP
NEW APPLICATION ENTERED
07/26/2019
Continuous trademark protection
Get notified about every new filing that threatens BIOSYNTH CARBOSYNTH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.